Navigation Links
Last step leading to blood cell formation elucidated
Date:4/1/2009

These new insights represent an important contribution to future clinical therapeutic approaches. The study was published in the prestigious science journal Nature and will be a central topic of the international symposium on the molecular mechanisms of hematopoiesis, which will take place in Munich from April 2nd to 4th.

The findings on the molecular mechanisms of blood formation (hematopoiesis) will be presented in Munich at the international symposium "Molecular Mechanisms of Normal and Malignant Hematopoiesis" from April 2nd to 4th. A question that has puzzled researchers for decades could now be solved: How are the first blood cells generated in the embryo? In particular, Dr. Timm Schroeder, research group leader at the Institute of Stem Cell Research of Helmholtz Zentrum Muenchen and his team found out that a special type of endothelial cells exists that can transform themselves into blood cells. Endothelial cells line the interior surface of blood vessels.

Dr. Timm Schroeder explained: "It is extremely difficult to investigate the blood cell generation process. It occurs only very briefly, hidden from view in the embryo within the mother's uterus."

The scientists first had to create the technical means to continually observe the transformation process of endothelial cells into blood cells on the single-cell level over a longer period of time. Dr. Schroeder and his colleagues developed novel bioimaging techniques with which the behavior of large numbers of individual cells can be recorded and tracked. They combined optimized microscopy, incubation and imaging technology as well as novel software programs to track individual cells in time-lapse videos with sophisticated cell purification and cell culture techniques. Thus, the scientists could observe the behavior of many differentiating mesodermal cells over a period of up to one week.

By carefully analyzing thousands of cells and the molecules expressed by them, Dr. Schroeder and PhD student Hanna Eilken were able to detect several very rare endothelial cells that indeed transformed themselves into blood cells.

"As a next step, we will focus on the identification of molecules that regulate the specification of blood cells," Dr. Schroeder went on to say. "Ultimately, our objective is to understand the precise molecular mechanisms. Identifying the exact cell type generating blood cells is an important prerequisite for understanding what combination of molecules makes a cell a blood cell."

Besides giving more insight into the mechanisms of blood formation, the findings of this just-published study are important for improving production of blood cells in the laboratory for clinical therapies. A possible in vitro production of unlimited numbers of blood cells from embryonic stem cells holds great promise for new therapy approaches. However, to enable targeted, efficient and pure production of specific blood cells that are safe for clinical therapy, it is essential to precisely understand the necessary differentiation steps. Dr. Schroeder concluded: "Our study has now elucidated the last of these steps."

Directed by Professor Magdalena Gtz, the Institute of Stem Cell Research at Helmholtz Zentrum Mnchen combines research on stem cells of the nervous system, the hematopoietic system and of the endoderm. Especially in view of clinical applications, the objective of the Institute is to elucidate the underlying mechanisms for the specification of stem cells in order to utilize these in a targeted manner to repair damaged cells.


'/>"/>

Contact: Sven Winkle
sven.winkler@helmholtz-muenchen.de
0049-893-187-3946
Helmholtz Zentrum Mnchen - German Research Center for Environmental Health
Source:Eurekalert

Related medicine news :

1. Leading Autism Care Provider Invites MPs to Meet Residents and Staff for World Autism Awareness Day
2. Streamline Health to Deliver Hosted Document Workflow Solution to Leading West Coast University-Affiliated Surgery Department
3. Solos Endoscopy, Inc. Receives Purchase Order from Leading San Diego Healthcare Provider
4. Despite Patent Expiries of Leading Therapies, New Product Launches Will Drive a $4.6 Billion Increase in the Coronary Heart Disease Market
5. MTM Upgrades its Phone System to Ensure Leading edge Technology and Software Feature sets for Existing and Future Clients
6. MAGNET Selects MHS as Preferred Vendor of Leading Edge Supply Chain Solutions
7. Irelands PulseLearning Inks Agreement With Leading U.S. Insurance Industry Association
8. Leading Healthcare Organizations Share Successes Realized with MEDais Predictive Analytics
9. Gamma Pharmaceuticals Accepts PO From Leading St. Louis Missouri Distributor. Order Valued up to $850,000 Retail Market Value
10. Stereotaxis Signs Agreement With Leading Leasing Specialist to Offer Alternative Financing to Hospital Customers
11. Three Leading Proxy Advisory Firms are Unanimous in Recommending LCA-Vision Stockholders Support the Current Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  Guerbet announced today that ... Supplier Horizon Award . One of ... was recognized for its support of Premier members through ... clinical excellence, and commitment to lower costs. ... this recognition of our outstanding customer service from Premier," ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Volumes: Global Analysis (United States, China, Japan, Brazil, United ... to their offering. ... healthcare business planners, provides surgical procedure volume data in ... with an in-depth analysis of growth drivers and inhibitors, ...
(Date:6/23/2016)... The Biotechnology industry might still ... great opportunities to investors. Stock-Callers.com assesses the recent performances ... XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ARNA ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... your complimentary trade alerts at: http://stock-callers.com/registration ...
Breaking Medicine Technology: